Predicting T-cell receptor (TCR)--peptide-MHC (pMHC) binding is central to vaccine design and T-cell therapy, yet deployed models frequently encounter epitopes unseen during training, causing silent overconfidence and unreliable prioritization. We address this by framing TCR--pMHC prediction as a \emph{selective prediction} problem: a calibrated model should either output a trustworthy confidence score or explicitly abstain. Concretely, we (1) introduce a dual-encoder architecture encoding both CDR3α/CDR3β and peptide sequences via a pre-trained protein language model; (2) apply temperature scaling to correct systematic probability miscalibration; and (3) impose a conformal abstention rule that provides finite-sample coverage guarantees at a user-specified target error rate. Evaluated under three split strategies -- random, epitope-held-out, and distance-aware -- our method achieves AUROC 0.813 and ECE 0.043 under the challenging epitope-held-out protocol, reducing ECE by 69.7\% relative to an uncalibrated baseline. At 80\% coverage, the selective model further reduces error rate from 18.7\% to 10.9\%, demonstrating that calibrated abstention enables principled coverage-risk trade-offs aligned with practical screening budgets.
Cite
@article{arxiv.2604.13254,
title = {Calibrated Abstention for Reliable TCR--pMHC Binding Prediction under Epitope Shift},
author = {Arman Bekov and Timur Bekzhanov and Bekzat Sadykov},
journal= {arXiv preprint arXiv:2604.13254},
year = {2026}
}